These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33306115)

  • 1. Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.
    Nguemeni Tiako MJ; Culhane J; South E; Srinivas SK; Meisel ZF
    JAMA Netw Open; 2020 Dec; 3(12):e2029043. PubMed ID: 33306115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
    Patrick SW; Faherty LJ; Dick AW; Scott TA; Dudley J; Stein BD
    JAMA; 2019 Jan; 321(4):385-393. PubMed ID: 30694320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.
    Knudsen HK
    J Stud Alcohol Drugs; 2015 Jul; 76(4):644-54. PubMed ID: 26098042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Distribution, and Characteristics Associated With Possession of Buprenorphine Waivers Among Infectious Diseases Physicians in the United States.
    Fujita AW; Loughry N; Moore DE; Carter AE; Hussen SA; Cooper H; Colasanti JA; Sheth AN
    Clin Infect Dis; 2023 Apr; 76(7):1197-1204. PubMed ID: 36419250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of buprenorphine and methadone in the management of maternal opioid use disorder in full term pregnancies.
    Staszewski CL; Garretto D; Garry ET; Ly V; Davis JA; Herrera KM
    J Perinat Med; 2020 Sep; 48(7):677-680. PubMed ID: 32681781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome.
    Wolf ER; Tong ST; Sabo RT; Woolf SH; Abbinanti K; Pecsok J; Krist AH
    BMC Pediatr; 2019 Oct; 19(1):371. PubMed ID: 31640614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
    Andrilla CHA; Moore TE; Patterson DG; Larson EH
    J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
    Grove LR; Rao N; Domino ME
    Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
    Wang S; Meador KJ; Pawasauskas J; Lewkowitz AK; Ward KE; Brothers TN; Hartzema A; Quilliam BJ; Wen X
    Drug Saf; 2023 Mar; 46(3):257-271. PubMed ID: 36642778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
    Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.
    Faherty LJ; Kranz AM; Russell-Fritch J; Patrick SW; Cantor J; Stein BD
    JAMA Netw Open; 2019 Nov; 2(11):e1914078. PubMed ID: 31722022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
    Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
    Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
    Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
    Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
    Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
    JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.